Home / Stock ratings / Financial Stocks / MET

Stock rating · Life Insurance

MetLife, Inc. (MET) Stock Rating & Analysis

As of November 20, 2026, MELANY rates MetLife, Inc. 62 out of 100 (Hold). Its highest factor score is risk-adjusted profile at 75, and its lowest is catalyst setup at 36.

MELANY ratingRated 2026-11-20

MET · composite score

62/100
Hold
Nov 20
Rating date
Live price in the app →
Quality55
Momentum62
Risk-adjusted75
Source basis SEC filings and live market dataDated snapshot

About MetLife, Inc.

MetLife is one of the largest US life insurers by assets, offering a range of life insurance and annuity products. It operates through six segments - Group Benefits, Retirement and Income Solutions, Asia, Latin America, EMEA, and MetLife Holdings (run-off products) - with the US-based Group Benefits and RIS contributing about 48% of 2024 adjusted earnings and the Asia segment about 25%, mostly tied to Japan.

Rating as of 2026-11-20 · this is a dated snapshot; the live rating and the live price are in the app (the rating is part of Pro, free for 30 days).

Why MET scores 62/100

MET's 8 factor scores run from 36 to 75, and 4 of them sit above its composite of 62. Here is how MET breaks down.

Valuation65/100

Whether the price looks cheap or expensive against earnings, growth, and peers.

  • Forward P/E 8.6x, earnings growth accelerating
  • PEG ratio 0.53 (< 1 = undervalued)
Business quality55/100

Margins, returns on capital, and balance-sheet strength.

Price momentum62/100

Direction and relative strength of the recent share-price trend.

  • 50-day MA above 200-day (golden cross zone)
Earnings track record73/100

History of beating or missing estimates, and where estimates are heading.

  • Beat EPS estimates 3 of last 4 quarters
Analyst sentiment68/100

What Wall Street price targets and revisions are signalling.

Catalyst setup36/100

Near-term events that could move the stock.

Risk-adjusted profile75/100

Upside weighed against volatility and drawdown risk.

Macro fit50/100

How the current rate and market regime suits this kind of company.

How MET compares

As of November 20, 2026, MetLife, Inc. is tied for 4th of 21 in Financial Stocks, where the average score is 59.

All stock rating pages.

Interest rates and MET

MetLife, Inc. sits in a group where interest rates are one of the forces at work. MELANY's macro fit factor, which weighs the rate environment, reads 50/100 for MET as of November 20, 2026. Today's rate read, free and dated: the 10-Year Treasury today and MBS prices today.

Key risks for MET

  • Performance partly driven by Financials / rate cycle, rotation away from this theme would hurt

Sector and theme context

MetLife, Inc. sits in the Financials / rate cycle theme, which MELANY currently rates 94/100 for strength. Theme strength feeds MET's momentum and catalyst factors above.

Tracking MET

MetLife, Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Add MET to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.

How MELANY rates MET

MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. MetLife, Inc.'s 62/100 reflects mature factor weighting for its profile.

Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.

Frequently asked questions about MET

Is MetLife, Inc. (MET) a buy?

As of 2026-11-20, MELANY rated MetLife, Inc. Hold with a composite score of 62/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.

How does MET rank against similar companies?

As of November 20, 2026, MetLife, Inc. is tied for 4th of 21 in MELANY's Financial Stocks list, where the average score is 59. Among the other names in the list, the highest scores belong to AIG (65) and COF (63).

Should I buy MetLife, Inc. stock?

That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates MetLife, Inc. (MET) Hold with a composite of 62/100 as of 2026-11-20. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.

What is the MET stock price forecast?

MELANY does not publish price targets or forecasts for MET. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 62/100 across eight factors for MetLife, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive. What it does read for MET as of 2026-11-20: its analyst sentiment factor is 68/100, and its price momentum factor is 62/100.

Is MET stock overvalued or undervalued?

MELANY's valuation factor currently reads 65/100 for MetLife, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives MET's read.

What price should I buy MET at?

MELANY is not flagging a fresh entry for MET at its current Hold rating, so there is no entry zone to publish right now. Add MET to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.

What are the risks of buying MET stock?

The top risks MELANY currently flags for MetLife, Inc.: Performance partly driven by Financials / rate cycle, rotation away from this theme would hurt. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.

Is MetLife, Inc. a good long-term investment?

For long-term durability the two factors that matter most are business quality, which MELANY scores 55/100 for MetLife, Inc., and earnings track record, at 73/100. The 62/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.

Will MET stock go up?

Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 62/100 for MET right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.

How current is this MET rating?

The rating on this page is a snapshot of MELANY's read as of 2026-11-20, and the score is not recomputed on this page. MELANY re-scores MET as new price, earnings, and fundamental data arrive; the current rating and the live price are in the app (the rating is part of Pro, free for 30 days).

How this rating works

Market Eyes Live

Every rating graded in public, MET included

MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.

Get the free iOS app Create a free account on the web Free account, no card. Pro: 30 days free, then $9.99 a month.